Respiri Ltd (RSH) - Total Assets
Based on the latest financial reports, Respiri Ltd (RSH) holds total assets worth AU$7.08 Million AUD (≈ $5.01 Million USD) as of December 2024. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See what is Respiri Ltd's book value for net asset value and shareholders' equity analysis.
Respiri Ltd - Total Assets Trend (1999–2024)
This chart illustrates how Respiri Ltd's total assets have evolved over time, based on quarterly financial data.
Respiri Ltd - Asset Composition Analysis
Current Asset Composition (June 2024)
Respiri Ltd's total assets of AU$7.08 Million consist of 65.2% current assets and 34.8% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 12.3% |
| Accounts Receivable | AU$234.05K | 3.8% |
| Inventory | AU$2.75 Million | 44.5% |
| Property, Plant & Equipment | AU$0.00 | 0.0% |
| Intangible Assets | AU$83.00K | 1.3% |
| Goodwill | AU$1.96 Million | 31.6% |
Asset Composition Trend (1999–2024)
This chart illustrates how Respiri Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see RSH company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Respiri Ltd's current assets represent 65.2% of total assets in 2024, a decrease from 99.0% in 1999.
- Cash Position: Cash and equivalents constituted 12.3% of total assets in 2024, down from 96.0% in 1999.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 32.0% of total assets, an increase from 0.0% in 1999.
- Asset Diversification: The largest asset category is inventory at 44.5% of total assets.
Respiri Ltd Competitors by Total Assets
Key competitors of Respiri Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Vitrolife AB
ST:VITR
|
Sweden | Skr11.12 Billion |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
|
China | CN¥805.10 Million |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.00 Billion |
|
Lumos Diagnostics Holdings Ltd
AU:LDX
|
Australia | AU$20.81 Million |
|
T&R Biofab Co. Ltd
KQ:246710
|
Korea | ₩83.86 Billion |
|
Ok Biotech Co Ltd
TW:4155
|
Taiwan | NT$3.89 Billion |
|
Promimic AB
ST:PRO
|
Sweden | Skr75.71 Million |
|
Memphasys Ltd
AU:MEM
|
Australia | AU$10.45 Million |
Respiri Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.28 | 1.62 | 0.75 |
| Quick Ratio | 0.94 | 1.09 | 0.75 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | AU$2.78 Million | AU$1.62 Million | AU$-425.42K |
Respiri Ltd - Advanced Valuation Insights
This section examines the relationship between Respiri Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 11.46 |
| Latest Market Cap to Assets Ratio | 6.30 |
| Asset Growth Rate (YoY) | 94.6% |
| Total Assets | AU$6.19 Million |
| Market Capitalization | $39.01 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Respiri Ltd's assets at a significant premium (6.30x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Respiri Ltd's assets grew by 94.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Respiri Ltd (1999–2024)
The table below shows the annual total assets of Respiri Ltd from 1999 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-06-30 | AU$6.19 Million ≈ $4.38 Million |
+94.60% |
| 2023-06-30 | AU$3.18 Million ≈ $2.25 Million |
-24.35% |
| 2022-06-30 | AU$4.21 Million ≈ $2.98 Million |
-53.83% |
| 2021-06-30 | AU$9.11 Million ≈ $6.44 Million |
+97.18% |
| 2020-06-30 | AU$4.62 Million ≈ $3.27 Million |
+355.69% |
| 2019-06-30 | AU$1.01 Million ≈ $717.19K |
-61.91% |
| 2018-06-30 | AU$2.66 Million ≈ $1.88 Million |
+0.75% |
| 2017-06-30 | AU$2.64 Million ≈ $1.87 Million |
-47.99% |
| 2016-06-30 | AU$5.08 Million ≈ $3.59 Million |
-2.06% |
| 2015-06-30 | AU$5.18 Million ≈ $3.67 Million |
-51.10% |
| 2014-06-30 | AU$10.60 Million ≈ $7.50 Million |
+273.68% |
| 2013-06-30 | AU$2.84 Million ≈ $2.01 Million |
-8.84% |
| 2012-06-30 | AU$3.11 Million ≈ $2.20 Million |
-7.18% |
| 2011-06-30 | AU$3.35 Million ≈ $2.37 Million |
-27.02% |
| 2010-06-30 | AU$4.60 Million ≈ $3.25 Million |
-9.93% |
| 2009-06-30 | AU$5.10 Million ≈ $3.61 Million |
-11.55% |
| 2008-06-30 | AU$5.77 Million ≈ $4.08 Million |
+88.95% |
| 2007-06-30 | AU$3.05 Million ≈ $2.16 Million |
+622.65% |
| 2006-06-30 | AU$422.38K ≈ $298.86K |
-73.47% |
| 2005-06-30 | AU$1.59 Million ≈ $1.13 Million |
+22.01% |
| 2004-06-30 | AU$1.30 Million ≈ $923.34K |
+133.22% |
| 2003-06-30 | AU$559.54K ≈ $395.91K |
-77.96% |
| 2002-06-30 | AU$2.54 Million ≈ $1.80 Million |
-82.94% |
| 2001-06-30 | AU$14.88 Million ≈ $10.53 Million |
+44.30% |
| 2000-06-30 | AU$10.31 Million ≈ $7.30 Million |
-39.57% |
| 1999-06-30 | AU$17.06 Million ≈ $12.07 Million |
-- |
About Respiri Ltd
Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia and the United States. The company develops, produces, and sells mobile health applications. Its products include wheezo, a wheeze rate detector; respiri mobile application; and Respiri health portal. The company was formerly known as iSonea Limited and changed its name to Respiri Limi… Read more